Loading…
Beneficial Effects of a Novel Inhibitor of Platelet-Derived Growth Factor Receptor Autophosphorylation in the Rat with Mesangial Proliferative Glomerulonephritis
1. Our original compound, Ki6896 ((4- t-butylphenyl){4-[(6,7-dimethoxy-4-quinolyl) oxy]phenyl} methanone) strongly inhibited the autophosphorylation of platelet-derived growth factor (PDGF) β-receptor (IC 50=0.31 μM) and that of basic fibroblast growth factor receptor (IC 50=3.1 μM), whereas it did...
Saved in:
Published in: | General pharmacology 1998-11, Vol.31 (5), p.765-773 |
---|---|
Main Authors: | , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | 1.
Our original compound, Ki6896 ((4-
t-butylphenyl){4-[(6,7-dimethoxy-4-quinolyl) oxy]phenyl} methanone) strongly inhibited the autophosphorylation of platelet-derived growth factor (PDGF) β-receptor (IC
50=0.31 μM) and that of basic fibroblast growth factor receptor (IC
50=3.1 μM), whereas it did not inhibit some other kinases.
2.
The [
3H]thymidine incorporation and the growth of mesangial cells under the stimulation of PDGF were inhibited by Ki6896 in a dose-dependent manner.
3.
In the mesangial proliferative glomerulonephritis rats induced by anti-Thy-1 monoclonal antibody, glomerulosclerosis was ameliorated and the number of glomerular proliferating cells was decreased by the daily administration of Ki6896. However, the accumulation of type I collagen and fibronectin in the glomeruli was not suppressed by Ki6896. |
---|---|
ISSN: | 0306-3623 1879-0011 |
DOI: | 10.1016/S0306-3623(98)00104-9 |